Ingredient
Isopropylphthalimide
Isopropylphthalimide is flagged for pregnancy, trying to conceive, breastfeeding and PCOS. The concern behind the strongest flag is absorbed into the body and fetal development.
- N-Isopropylphthalimide
- 2-Isopropyl-1H-isoindole-1,3(2H)-dione
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 4 of 6
- Counting avoid, high risk and medium risk
- Last checked
- 15 September 2026
- The day this assessment was read from the catalogue
Isopropylphthalimide and pregnancy
Not Recommended
- Absorbed into the body
- Fetal development
Isopropylphthalimide is a synthetic solvent with a chemical structure related to phthalimide compounds. While it is not a phthalate, its structural similarity raises theoretical concerns about potential developmental effects. No studies have specifically examined the safety of topical isopropylphthalimide during pregnancy. Given its chemical structure and the known concerns about phthalate-related compounds as potential endocrine disruptors, most toxicologists would recommend caution. The lack of safety data combined with theoretical mechanisms of concern makes this ingredient one to avoid during pregnancy as a precautionary measure. While no regulatory body has explicitly prohibited this ingredient, the principle of avoiding chemicals with unknown pregnancy safety profiles is widely recommended by ACOG. Pregnant women are advised to minimize exposure to chemicals with insufficient safety data, particularly during the critical first trimester when organ development occurs.
Isopropylphthalimide and breastfeeding
Caution Advised
- Absorbed into the body
- Infant exposure
As a solvent, isopropylphthalimide may have some degree of skin penetration, though specific absorption data is not available. The compound's molecular structure suggests it could potentially enter systemic circulation and theoretically transfer to breast milk. Without specific studies on breastfeeding safety, dermatologists typically recommend avoiding ingredients with unknown profiles when safer alternatives exist. The structural relationship to phthalimide compounds and lack of established safety data creates uncertainty about potential infant exposure through breast milk. Most lactation consultants and dermatologists advise choosing well-studied ingredients during breastfeeding. While the actual risk is unknown, the precautionary principle suggests selecting products with established safety profiles rather than experimental or poorly-studied compounds.
Isopropylphthalimide and postpartum
Safe to Use
- Irritant
For postpartum women who are not breastfeeding, the primary concerns with isopropylphthalimide relate to potential skin irritation rather than systemic effects. The ingredient functions as a solvent and may cause sensitivity in some individuals. Without specific reproductive concerns in non-pregnant, non-breastfeeding women, this ingredient poses minimal known risks beyond general cosmetic safety considerations. However, the limited safety data means that individuals with sensitive skin may wish to patch test products containing this ingredient.
Isopropylphthalimide and trying to conceive
Not Recommended
- Hormone disruptor
- Builds up in tissue
Women trying to conceive should apply the same precautionary approach as pregnant women, since conception timing is often uncertain. Isopropylphthalimide's lack of safety data and structural similarity to compounds with endocrine concerns makes it an ingredient to avoid during the preconception period. Fertility specialists often recommend discontinuing use of poorly-studied chemicals at least three months before attempting conception to allow any accumulated substances to clear from the body. This precautionary approach helps minimize potential exposure during early pregnancy when women may not yet know they have conceived.
Isopropylphthalimide and PCOS
Caution Advised
- Interferes with hormones
Isopropylphthalimide's structural similarity to phthalimide compounds raises theoretical concerns about potential endocrine activity, though no specific studies have examined its effects on hormone balance or PCOS symptoms. Women with PCOS often have existing hormonal imbalances, and some dermatologists recommend avoiding ingredients with potential endocrine-disrupting properties, even when evidence is limited. The lack of safety data combined with structural concerns makes this an ingredient that PCOS patients may wish to avoid as a precautionary measure. While no direct evidence links this ingredient to hormonal disruption, the principle of avoiding poorly-studied chemicals with theoretical mechanisms of concern is often applied in managing PCOS. Women with PCOS seeking to minimize potential hormone disruptors may prefer products with well-established safety profiles.
Isopropylphthalimide and general use
Safe to Use
- Irritant
- Common allergen
For the general population without specific reproductive concerns, isopropylphthalimide functions as a solvent in cosmetic formulations. Its primary safety considerations relate to potential skin irritation or sensitization rather than systemic toxicity. The limited safety data available suggests that this ingredient may cause irritation in sensitive individuals, though severe reactions have not been widely reported. As with any cosmetic ingredient, patch testing is advisable for those with reactive skin. While not banned or restricted by major regulatory bodies, the ingredient's limited use and lack of extensive safety testing means that consumers seeking thoroughly-vetted ingredients may prefer alternatives. However, for healthy adults without skin sensitivities, occasional exposure in cosmetic products is unlikely to pose significant risk.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Isopropylphthalimide, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store